Tom Murphy

June 11, 2012 | Daily Report Online

Insurer UnitedHealth Group Inc. sees some parts of the health care overhaul as sound medicine and plans to keep them even if the law fails to survive an upcoming Supreme Court ruling.

By Tom Murphy

4 minute read

February 29, 2008 | Daily Report Online

INDIANAPOLIS AP - Eli Lilly and Co. finally heads to court next week to fight the long-standing accusation that it failed to warn doctors and patients about complications tied to its top-selling drug Zyprexa.Lilly will face the state of Alaska in a trial in Anchorage that centers on Medicaid patients who use Zyprexa, an anti-psychotic that treats schizophrenia and bipolar disorder.

By TOM MURPHY

3 minute read

December 20, 2012 | New York Law Journal

Eastern District Judge Sterling Johnson, Jr. accepted the guilty plea and approved Amgen's global settlement.

By Ross Todd and Tom Murphy

5 minute read

January 16, 2009 | Daily Report Online

INDIANAPOLIS AP - Eli Lilly Co. taught its sales force a catchy slogan to peddle the antipsychotic drug Zyprexa for treating the elderly.Company salespeople told care providers that 5 milligrams of Zyprexa at 5 p.m. - or "5 at 5" - would help dementia patients sleep.Only problem: Regulators never approved selling the drug for dementia, and federal prosecutors say marketing like that led to a record $1.

By TOM MURPHY and MARLEY SEAMAN

4 minute read

February 01, 2008 | National Law Journal

Eli Lilly has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better. Two shareholders have sued Lilly in federal court in Indiana, accusing Lilly executives and directors of recklessly disregarding risks posed by illegal drug marketing tactics, which have been alleged in lawsuits and newspaper articles. A Lilly spokesman calls the lawsuit "groundless."

By Tom Murphy

4 minute read

February 10, 2009 | Daily Report Online

INDIANAPOLIS AP - The American Medical Association is joining several state associations in suing health insurers Aetna Inc. and Cigna Corp. over a database they say was rigged to underpay doctors on out-of-network claims for more than a decade.But Cigna says the rates doctors charge are part of the problem.The lawsuits heap more criticism on Ingenix Inc.

By TOM MURPHY and DAMIAN J. TROISE

4 minute read

February 01, 2008 | Daily Report Online

INDIANAPOLIS AP - Eli Lilly and Co. has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better.Two shareholders have accused Lilly executives and directors of recklessly disregarding risks posed by illegal drug marketing tactics, which have been alleged in lawsuits and newspaper articles.

By TOM MURPHY

4 minute read

June 14, 2007 | Law.com

Eli Lilly and Co., which has faced thousands of suits over its anti-psychotic Zyprexa, says lawyers' ads about the drug are prompting patients to stop taking mental illness medications when they shouldn't. Results of a company-funded survey of 402 psychiatrists show that more than half said they believed that their patients who stopped or reduced their medication did so after seeing the commercials, which one critic said have an "ambulance-chasing feel to them."

By Tom Murphy

4 minute read

December 19, 2008 | Corporate Counsel

A federal judge on Dec. 18 gave preliminary approval to a $900 million-plus settlement that resolves a lawsuit pitting UnitedHealth Group shareholders against the insurer over its stock options. Minnetonka, Minn.-based UnitedHealth has agreed to pay $895 million to settle the class-action case.

By Tom Murphy

3 minute read